CG Invites Co (083790.KQ) Osake Kurssi

CG Invites Co Ltd, listed on the Korea Exchange with ticker 083790.KQ and ISIN KR7083790006, is a company based in Seongnam, South Korea. It operates within the Health Care sector, specifically in the Biotechnology industry. The company went public through an IPO on January 6, 2006. Its official website is http://www.cgxinc.com/. According to the provided information, CG Invites Co Ltd is engaged in the discovery and development of novel therapeutics. The company's operations are structured into three segments: Finished Pharmaceuticals Manufacturing, which involves the production and sale of finished pharmaceutical products; Pharmaceutical R&D Division, which provides clinical trial analysis, technical services, and sells new drugs; and an Other segment that handles the manufacture and sale of hot fats and other household items. The company also mentions operating in the real estate leasing business, though this detail is not clearly assigned to a specific segment. The source description references CrystalGenomics, Inc. as the company's name, but the official name provided is CG Invites Co Ltd, which may indicate a possible discrepancy or rebranding. The company's activities are centered around biotechnology and pharmaceuticals, with a focus on research, development, and manufacturing of therapeutic products. It does not provide specific details on revenue, employee count, or other financial metrics beyond the IPO date.